Waters Corporation (WAT) is set to announce its fiscal Q4 earnings, with analysts expecting a profit of $4.50 per share, up 9.8% from the year-ago quarter. For fiscal 2025, analysts anticipate a profit of $13.10 per share, a 10.5% increase from fiscal 2024. Despite underperforming the S&P 500 Index and the State Street Health Care Select Sector SPDR ETF over the past year, Waters Corp’s stock faced downward pressure due to concerns around its merger with Becton Dickinson’s Biosciences & Diagnostic Solutions business. Wall Street analysts cautiously recommend a “Moderate Buy” rating for the stock, with a mean price target of $419.44.

Read more at Barchart: Waters Corporation Earnings Preview: What to Expect